T-cell mineralocorticoid receptor controls blood pressure by regulating interferon-gamma

Circulation Research

Volumn 120, Issue 10, 2017, Pages 1584-1597

  Sun, Xue Nan ^a,b,c   Li, Chao ^a,b,c   Liu, Yuan ^a,b,c   Du, Lin Juan ^a,b,c   Zeng, Meng Ru ^a,b,c   Zheng, Xiao Jun ^a,b,c   Zhang, Wu Chang ^a,b,c   Liu, Yan ^a   Zhu, Mingjiang ^c   Kong, Deping ^c   Zhou, Li ^e   Lu, Limin ^e   Shen, Zhu Xia ^c,e   Yi, Yi ^b   Du, Lili ^b   Qin, Mu ^b   Liu, Xu ^b   Hua, Zichun ^f   Sun, Shuyang ^b   Yin, Huiyong ^c   Zhou, Bin ^d   Yu, Ying ^c,g   Zhang, Zhiyuan ^b   Duan, Sheng Zhong ^a,b   more..

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^d INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^e FUDAN UNIVERSITY   (China)

^f NANJING UNIVERSITY   (China)

^g TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

hypertension; inflammation; interferon gamma; mineralocorticoid receptor; T cell

Indexed keywords

ANGIOTENSIN II; EPLERENONE; GAMMA INTERFERON; MINERALOCORTICOID RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTRALIZING ANTIBODY; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; OSTEOPONTIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT1; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; ACETYLCHOLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL INJURY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIASTOLIC BLOOD PRESSURE; EXPERIMENTAL HYPERTENSION; FLOW CYTOMETRY; IN VITRO STUDY; KIDNEY INJURY; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SYSTOLIC BLOOD PRESSURE; ANIMAL; BLOOD PRESSURE; C57BL MOUSE; CELL CULTURE; DOSE RESPONSE; DRUG EFFECTS; GENETICS; HYPERTENSION; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; T LYMPHOCYTE;

ACETYLCHOLINE; ANIMALS; BLOOD PRESSURE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERTENSION; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, MINERALOCORTICOID; T-LYMPHOCYTES;

EID: 85015710092     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.310480     Document Type: Article

References (47)

1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jimenez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB, Executive summary: Heart disease and stroke statistics-2016 update: A report from the american heart association. Circulation 2016 133 447 454
2. Rahimi K, Emdin CA, MacMahon S, The epidemiology of blood pressure and its worldwide management. Circ Res 2015 116 925 936. doi: 10.1161/CIRCRESAHA.116.304723.
3. Wright JT Jr., Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, Reboussin DM, Rahman M, Oparil S, Lewis CE, Kimmel PL, Johnson KC, Goff DC Jr., Fine LJ, Cutler JA, Cushman WC, Cheung AK, Ambrosius WT, A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015 373 2103 2116
4. Oparil S, Schmieder RE, New approaches in the treatment of hypertension. Circ Res 2015 116 1074 1095. doi: 10.1161/CIRCRESAHA.116.303603.
5. McMaster WG, Kirabo A, Madhur MS, Harrison DG, Inflammation, immunity, and hypertensive end-organ damage. Circ Res 2015 116 1022 1033. doi: 10.1161/CIRCRESAHA.116.303697.
6. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG, Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 2007 204 2449 2460. doi: 10.1084/jem.20070657.
7. Vinh A, Chen W, Blinder Y, Weiss D, Taylor WR, Goronzy JJ, Weyand CM, Harrison DG, Guzik TJ, Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension. Circulation 2010 122 2529 2537. doi: 10.1161/CIRCULATIONAHA.109.930446.
8. Rudemiller N, Lund H, Jacob HJ, Geurts AM, Mattson DL, PhysGen Knockout Program CD247 modulates blood pressure by altering T-lymphocyte infiltration in the kidney. Hypertension 2014 63 559 564. doi: 10.1161/HYPERTENSIONAHA.113.02191.
9. Trott DW, Thabet SR, Kirabo A, Saleh MA, Itani H, Norlander AE, Wu J, Goldstein A, Arendshorst WJ, Madhur MS, Chen W, Li CI, Shyr Y, Harrison DG, Oligoclonal CD8+ T cells play a critical role in the development of hypertension. Hypertension 2014 64 1108 1115. doi: 10.1161/HYPERTENSIONAHA.114.04147.
10. Lother A, Moser M, Bode C, Feldman RD, Hein L, Mineralocorticoids in the heart and vasculature: new insights for old hormones. Annu Rev Pharmacol Toxicol 2015 55 289 312. doi: 10.1146/annurev-pharmtox-010814-124302.
11. Ferrario CM, Schiffrin EL, Role of mineralocorticoid receptor antagonists in cardiovascular disease. Circ Res 2015 116 206 213. doi: 10.1161/CIRCRESAHA.116.302706.
12. Colussi G, Catena C, Sechi LA, Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension. J Hypertens 2013 31 3 15. doi: 10.1097/HJH.0b013e3283599b6a.
13. Levy DG, Rocha R, Funder JW, Distinguishing the antihypertensive and electrolyte effects of eplerenone. J Clin Endocrinol Metab 2004 89 2736 2740. doi: 10.1210/jc.2003-032149.
14. McCurley A, Pires PW, Bender SB, Aronovitz M, Zhao MJ, Metzger D, Chambon P, Hill MA, Dorrance AM, Mendelsohn ME, Jaffe IZ, Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors. Nat Med 2012 18 1429 1433. doi: 10.1038/nm.2891.
15. Nguyen Dinh Cat A, Griol-Charhbili V, Loufrani L, Labat C, Benjamin L, Farman N, Lacolley P, Henrion D, Jaisser F, The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure. FASEB J 2010 24 2454 2463. doi: 10.1096/fj.09-147926.
16. Mueller KB, Bender SB, Hong K, Yang Y, Aronovitz M, Jaisser F, Hill MA, Jaffe IZ, Endothelial mineralocorticoid receptors differentially contribute to coronary and mesenteric vascular function without modulating blood pressure. Hypertension 2015 66 988 997. doi: 10.1161/HYPERTENSIONAHA.115.06172.
17. Rickard AJ, Morgan J, Chrissobolis S, Miller AA, Sobey CG, Young MJ, Endothelial cell mineralocorticoid receptors regulate deoxycorticosterone/salt-mediated cardiac remodeling and vascular reactivity but not blood pressure. Hypertension 2014 63 1033 1040. doi: 10.1161/HYPERTENSIONAHA.113.01803.
18. Rickard AJ, Morgan J, Tesch G, Funder JW, Fuller PJ, Young MJ, Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone/salt-induced cardiac fibrosis and increased blood pressure. Hypertension 2009 54 537 543. doi: 10.1161/HYPERTENSIONAHA.109.131110.
19. Usher MG, Duan SZ, Ivaschenko CY, Frieler RA, Berger S, Schütz G, Lumeng CN, Mortensen RM, Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice. J Clin Invest 2010 120 3350 3364. doi: 10.1172/JCI41080.
20. Berger S, Wolfer DP, Selbach O, Alter H, Erdmann G, Reichardt HM, Chepkova AN, Welzl H, Haas HL, Lipp HP, Schütz G, Loss of the limbic mineralocorticoid receptor impairs behavioral plasticity. Proc Natl Acad Sci U S A 2006 103 195 200. doi: 10.1073/pnas.0503878102.
21. Lee PP, Fitzpatrick DR, Beard C, Jessup HK, Lehar S, Makar KW, Perez-Melgosa M, Sweetser MT, Schlissel MS, Nguyen S, Cherry SR, Tsai JH, Tucker SM, Weaver WM, Kelso A, Jaenisch R, Wilson CB, A critical role for dnmt1 and DNA methylation in t cell development, function, and survival. Immunity 2001 15 763 774
22. Zhang JD, Patel MB, Song YS, Griffiths R, Burchette J, Ruiz P, Sparks MA, Yan M, Howell DN, Gomez JA, Spurney RF, Coffman TM, Crowley SD, A novel role for type 1 angiotensin receptors on T lymphocytes to limit target organ damage in hypertension. Circ Res 2012 110 1604 1617. doi: 10.1161/CIRCRESAHA.111.261768.
23. Krege JH, Hodgin JB, Hagaman JR, Smithies O, A noninvasive computerized tail-cuff system for measuring blood pressure in mice. Hypertension 1995 25 1111 1115
24. Duan SZ, Ivashchenko CY, Whitesall SE, D'Alecy LG, Duquaine DC, Brosius FC 3rd, Gonzalez FJ, Vinson C, Pierre MA, Milstone DS, Mortensen RM, Hypotension, lipodystrophy, and insulin resistance in generalized PPARgamma-deficient mice rescued from embryonic lethality. J Clin Invest 2007 117 812 822. doi: 10.1172/JCI28859.
25. Li C, Zhang YY, Frieler RA, Zheng XJ, Zhang WC, Sun XN, Yang QZ, Ma SM, Huang B, Berger S, Wang W, Wu Y, Yu Y, Duan SZ, Mortensen RM, Myeloid mineralocorticoid receptor deficiency inhibits aortic constriction-induced cardiac hypertrophy in mice. PLoS One 2014 9 e110950. doi: 10.1371/journal.pone.0110950.
26. Carnevale D, Pallante F, Fardella V, Fardella S, Iacobucci R, Federici M, Cifelli G, De Lucia M, Lembo G, The angiogenic factor PlGF mediates a neuroimmune interaction in the spleen to allow the onset of hypertension. Immunity 2014 41 737 752. doi: 10.1016/j.immuni.2014.11.002.
27. Dikalov S, Griendling KK, Harrison DG, Measurement of reactive oxygen species in cardiovascular studies. Hypertension 2007 49 717 727. doi: 10.1161/01.HYP.0000258594.87211.6b.
28. Saleh MA, McMaster WG, Wu J, Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation. J Clin Invest 2015 125 1189 1202. doi: 10.1172/JCI76327.
29. Armanini D, Endres S, Kuhnle U, Weber PC, Parallel determination of mineralocorticoid and glucocorticoid receptors in T-And B-lymphocytes of human spleen. Acta Endocrinol (Copenh) 1988 118 479 482
30. Schmieder RE, End organ damage in hypertension. Dtsch Arztebl Int 2010 107 866 873. doi: 10.3238/arztebl.2010.0866.
31. Heijnen BF, Van Essen H, Schalkwijk CG, Janssen BJ, Struijker-Boudier HA, Renal inflammatory markers during the onset of hypertension in spontaneously hypertensive rats. Hypertens Res 2014 37 100 109. doi: 10.1038/hr.2013.99.
32. Itani HA, Xiao L, Saleh MA, CD70 Exacerbates Blood Pressure Elevation and Renal Damage in Response to Repeated Hypertensive Stimuli. Circ Res 2016 118 1233 1243. doi: 10.1161/CIRCRESAHA.115.308111.
33. Touyz RM, Molecular and cellular mechanisms in vascular injury in hypertension: role of angiotensin II. Curr Opin Nephrol Hypertens 2005 14 125 131
34. Macián F, López-Rodríguez C, Rao A, Partners in transcription: NFAT and AP-1. Oncogene 2001 20 2476 2489. doi: 10.1038/sj.onc.1204386.
35. Kiani A, García-Cózar FJ, Habermann I, Laforsch S, Aebischer T, Ehninger G, Rao A, Regulation of interferon-gamma gene expression by nuclear factor of activated T cells. Blood 2001 98 1480 1488
36. Teixeira LK, Fonseca BP, Vieira-de-Abreu A, Barboza BA, Robbs BK, Bozza PT, Viola JP, IFN-gamma production by CD8+ T cells depends on NFAT1 transcription factor and regulates Th differentiation. J Immunol 2005 175 5931 5939
37. Casares S, Stan AC, Bona CA, Brumeanu TD, Antigen-specific downregulation of T cells by doxorubicin delivered through a recombinant MHC II-peptide chimera. Nat Biotechnol 2001 19 142 147. doi: 10.1038/84404.
38. Frick SU, Domogalla MP, Baier G, Wurm FR, Mailaender V, Landfester K, Steinbrink K, Interleukin-2 functionalized nanocapsules for t cell-based immunotherapy. ACS Nano 2016
39. Youn JC, Yu HT, Lim BJ, Koh MJ, Lee J, Chang DY, Choi YS, Lee SH, Kang SM, Jang Y, Yoo OJ, Shin EC, Park S, Immunosenescent CD8+ T cells and C-X-C chemokine receptor type 3 chemokines are increased in human hypertension. Hypertension 2013 62 126 133. doi: 10.1161/HYPERTENSIONAHA.113.00689.
40. Amador CA, Barrientos V, Peña J, Herrada AA, González M, Valdés S, Carrasco L, Alzamora R, Figueroa F, Kalergis AM, Michea L, Spironolactone decreases DOCA-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes. Hypertension 2014 63 797 803. doi: 10.1161/HYPERTENSIONAHA.113.02883.
41. Herrada AA, Contreras FJ, Marini NP, Amador CA, González PA, Cortés CM, Riedel CA, Carvajal CA, Figueroa F, Michea LF, Fardella CE, Kalergis AM, Aldosterone promotes autoimmune damage by enhancing Th17-mediated immunity. J Immunol 2010 184 191 202. doi: 10.4049/jimmunol.0802886.
42. Martinez GJ, Pereira RM, Aijo T, Kim EY, Marangoni F, Pipkin ME, Togher S, Heissmeyer V, Zhang YC, Crotty S, Lamperti ED, Ansel KM, Mempel TR, Lahdesmaki H, Hogan PG, Rao A, The transcription factor nfat promotes exhaustion of activated cd8(+) t cells. Immunity 2015 42 265 278
43. Garcia AG, Wilson RM, Heo J, Murthy NR, Baid S, Ouchi N, Sam F, Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure. Am J Physiol Heart Circ Physiol 2012 303 H587 H596. doi: 10.1152/ajpheart.00298.2012.
44. Zhang J, Patel MB, Griffiths R, Mao A, Song YS, Karlovich NS, Sparks MA, Jin H, Wu M, Lin EE, Crowley SD, Tumor necrosis factor-produced in the kidney contributes to angiotensin II-dependent hypertension. Hypertension 2014 64 1275 1281. doi: 10.1161/HYPERTENSIONAHA.114.03863.
45. Kamat NV, Thabet SR, Xiao L, Saleh MA, Kirabo A, Madhur MS, Delpire E, Harrison DG, McDonough AA, Renal transporter activation during angiotensin-II hypertension is blunted in interferon-γ-/-And interleukin-17A-/-mice. Hypertension 2015 65 569 576. doi: 10.1161/HYPERTENSIONAHA.114.04975.
46. Farrar MA, Schreiber RD, The molecular cell biology of interferon-gamma and its receptor. Annu Rev Immunol 1993 11 571 611. doi: 10.1146/annurev.iy.11.040193.003035.
47. Mühl H, Pfeilschifter J, Anti-inflammatory properties of pro-inflammatory interferon-gamma. Int Immunopharmacol 2003 3 1247 1255. doi: 10.1016/S1567-5769(03)00131-0.